Last updated on August 2020

Phase IIb Study of Evobrutinib in Subjects With Rheumatoid Arthritis

Brief description of study

The purpose of the study is to determine the efficacy, dose response, and safety of evobrutinib in subjects with Rheumatoid Arthritis (RA), and to consider a dose to take forward into Phase III development.

Clinical Study Identifier: NCT03233230

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.